Consecutive Macular Edema and Visual Outcome in Branch Retinal Vein Occlusion

Table 3

Demographic data for each group.

Characteristic	Natural; course	IVB	IVTA	𝑃-value
Number of eyes	33	26	21
Gainer : nongainer (𝑛)	23 : 10	14 : 12	8 : 13
Mean patient age (years)*	57.57±9.06	57.61±12.11	63.7±11.57	0.487
Gender (M : F)	18 : 15	11 : 15	8 : 13	0.153
Baseline V/A (LogMAR)*	0.56±0.41	0.67±0.43	0.55±0.52	0.248
Baseline CMT (𝜇m)*	517.63±175.43	557.66±157.87	559.05±187.35	0.321
Duration of F/U (months)*	19.45±9.15	19.05±7.36	19.75±7.21	0.481
Number of injections*		2.21±0.42	2.56±0.78	0.165

∗Mean ± SD; IVB: intravitreal bevacizumab; IVTA: intravitreal triamcinolone acetonide; F/U: follow-up.